Flow cytometry is a widely used analytical technique that distinguishes between cell populations depending on the presence or absence of chosen markers. However, the number of markers that can be ...

High dimensional full spectrum flow cytometry holds the promise of addressing long-held questions in cellular biology. Fluorescent dye performance heavily impacts both the quality and the ...

Spectral flow cytometry collects the full emission spectrum of a fluorochrome, enabling multicolor panels with more parameters than conventional flow cytometry. As scientists discover the subtle ...

With flow cytometry, as with many technologies that enjoy continuous use, we can see an evolution of capabilities. Spectral analysis, image capture, and artificial intelligence are just a few of the ...

High dimensional full spectrum flow cytometry grants unprecedented access to previously unattainable parameters in cellular biology. Fluorescent dye performance heavily impacts both the quality and ...

A 24-parameter spectral flow cytometry panel was developed to monitor immune receptor expression in MS patients, aiding personalized treatment approaches. The panel detects 12 treatment-associated ...

Flow cytometry is an invaluable method for biomedical research. Since its development over 50 years ago, technology for flow cytometry has progressed rapidly, allowing for the detection of more and ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility. This ...

After five decades of use, flow cytometry is entrenched in biomedical science. Besides enabling the quick processing of cells in suspension, flow cytometry provides quantitative results across ...

FREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- With cancer research and diagnostics driving the need for deeper, faster cellular insights, spectral flow cytometry leader Cytek Biosciences, Inc.

This article and associated images are based on a poster originally authored by Sharon Sanderson, Michael Blundell, and Tracey Long and presented at ELRIG Drug Discovery 2025 in affiliation with ...